Sponsored by:

Nuclear Medicine: Page 138

AAA buys Atreus Pharmaceuticals
By AuntMinnie.com staff writers
Advanced Accelerator Applications (AAA) has purchased the remaining 49.9% of Canadian molecular imaging technology developer Atreus Pharmaceuticals.
January 8, 2015
PET links rehab with recovery from brain damage
By AuntMinnie.com staff writers
Using PET, Japanese researchers examined a special kind of neural plasticity that allows for motor function recovery during rehabilitation after brain damage, according to a study published in the January 7 issue of the Journal of Neuroscience.
January 7, 2015
Shine, Phoenix ink isotope supply deal
By AuntMinnie.com staff writers
Shine Medical Technologies and Phoenix Nuclear Labs have signed an exclusive long-term development and supply agreement for radioisotopes.
January 6, 2015
Eckert & Ziegler reports loss in Q4
By AuntMinnie.com staff writers
Isotope technology firm Eckert & Ziegler reported disappointing sales for the last quarter of 2014.
January 4, 2015
Zecotek settles Philips, Saint-Gobain lawsuits
By AuntMinnie.com staff writers
Nuclear medicine firm Zecotek Photonics announced that its subsidiary, Zecotek Imaging Systems, has settled its patent infringement lawsuits against Philips Healthcare and Saint-Gobain.
December 22, 2014
Economy will dictate global nuclear med sales through 2020
By AuntMinnie.com staff writers
The lackluster world economy and reimbursement issues will result in only modest growth in the global nuclear medicine imaging equipment market in this decade, according to a report from market research firm GlobalData.
December 16, 2014
Gamma Medica sets sights on continued progress in 2015
By Wayne Forrest
Molecular imaging developer Gamma Medica is hoping that 2015 will be a watershed year in its resurrection, some 21 months after emerging from Chapter 11 bankruptcy. The company has refreshed its technology and is building its installed base as it regains its footing.
December 15, 2014
2014 12 15 14 00 32 837 Gamma Medica Luma Gem Thumb
Radiopharma treatment can help cancer therapy
By AuntMinnie.com staff writers
Targeted therapy with radiopharmaceuticals could greatly improve cancer treatment, especially for cancer cells that have migrated from primary tumors to lymph nodes and secondary organs, according to a new study.
December 10, 2014
PET/MRI matches PET/CT in NSCLC accuracy
By Wayne Forrest
CHICAGO - Using a 15-minute MRI protocol with PET, Swiss researchers achieved diagnostic accuracy equal to that of PET/CT for patients with non-small cell lung cancer (NSCLC). Study results were presented on Wednesday at the RSNA conference.
December 3, 2014
2014 11 30 11 54 08 237 Rsna2014
Philips displays new spectral CT, MRI technology
By Brian Casey and Kate Madden Yee
CHICAGO - Philips Healthcare is highlighting a number of new technologies in its booth at RSNA 2014, including spectral CT and a new 1.5-tesla MRI scanner, as well as advancements in ultrasound, molecular imaging, and interventional x-ray.
December 2, 2014
2014 12 03 16 10 55 901 Philips Ingenia15 Ts Mri 200
Siemens RSNA highlights cover MRI, CT, US
By Brian Casey and Wayne Forrest
CHICAGO - Siemens Healthcare is promoting a range of new technologies in its booth at RSNA 2014, including a 1.5-tesla MRI scanner, a single-source CT scanner optimized for spectral imaging, and ultrasound and interventional x-ray enhancements.
December 1, 2014
2014 12 02 15 01 05 729 Magnetom Amira 200
GE revives Signa MRI brand, launches CT and DBT
By Brian Casey and Erik L. Ridley
CHICAGO - The return of its storied Signa brand in MRI, a new family of Revolution CT scanners, and a new digital breast tomosynthesis (DBT) system with market clearance are among the new product introductions at RSNA 2014 for multimodality vendor GE Healthcare.
December 1, 2014
2014 12 02 11 35 54 711 Ge Signa Pet Mr 200
Previous Page
Page 138 of 440
Next Page